Inflammation and Sleep

  • Rita A. Trammell
  • Krishna Jhaveri
  • Linda A. Toth


Inflammation is the physiological process by which vascularized tissues respond to an infectious agent, antigenic challenge, or physical injury. During the inflammatory process, soluble mediators and cellular components work together to contain and eliminate the agents causing physical distress. Although inflammation is crucial to maintaining the health and integrity of an individual organism, both inadequate and excessive immune responses are detrimental to the health and life of the host. When the inflammatory response is impaired, the host may be excessively susceptible to the detrimental effects of microbial or neoplastic disease. When the inflammatory response is poorly controlled, the host may experience significant or excessive tissue damage.


Human Immunodeficiency Virus Obstructive Sleep Apnea Chronic Fatigue Syndrome Newcastle Disease Virus Influenza Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbasi, F., Chu, J.W., Lamendola, C., McLaughlin, T., Hayden, J., Reaven, G.M., and Reaven, P.D. (2004) Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53, 585–590.PubMedGoogle Scholar
  2. Ablashi, D.V. (1994) Summary: Viral studies of chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1), S130–S133.PubMedGoogle Scholar
  3. Afari, N., and Buchwald, D. (2003) Chronic fatigue syndrome: A review. Am J Psychiatry 160, 221–236.PubMedGoogle Scholar
  4. Agarwal, R., and Gotman, J. (2001) Computer-assisted sleep staging. IEEE Trans Biomed Eng 48, 1412–1423.PubMedGoogle Scholar
  5. Agnese, D.M., Calvano, J.E., Hahm, S.J., Coyle, S.M., Corbett, S.A., Calvano, S.E., and Lowry, S.F. (2002) Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186, 1522–1525.PubMedGoogle Scholar
  6. Ajuwon, K.M., and Spurlock, M.E. (2005) Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 288, R1220–R1225.PubMedGoogle Scholar
  7. Al-Delaimy, W.K., Manson, J.E., Willett, W.C., Stampfer, M.J., and Hu, F.B. (2002) Snoring as a risk factor for type II diabetes mellitus: A prospective study. Am J Epidemiol 155, 387–393.PubMedGoogle Scholar
  8. Alt, J.A., Obal, F., Jr., Traynor, T.R., Gardi, J., Majde, J.A., and Krueger, J.M. (2003) Alterations in EEG activity and sleep after influenza viral infection in GHRH receptordeficient mice. J Appl Physiol 95, 460–468.PubMedGoogle Scholar
  9. Ancoli-Israel, S., Liu, L., Marler, M.R., Parker, B.A., Jones, V., Sadler, G.R., Dimsdale, J., Cohen-Zion, M., and Fiorentino, L. (2006) Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14, 201–209.PubMedGoogle Scholar
  10. Ashman, R.B., Fulurija, A., and Papadimitriou, J.M. (1997) Evidence that two independent host genes influence the severity of tissue damage and susceptibility to acute pyelonephritis in murine systemic candidiasis. Microb Pathogen 22, 187–192.Google Scholar
  11. Ayas, N.T., White, D.P., Al-Delaimy, W.K., Manson, J.E., Stampfer, M.J., Speizer, F.E., Patel, S., and Hu, F.B. (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26, 380–384.PubMedGoogle Scholar
  12. Balkwill, F., and Coussens, L.M. (2004) Cancer: An inflammatory link. Nature 431, 405–406.PubMedGoogle Scholar
  13. Barber, R.C., Aragaki, C.C., Rivera-Chavez, F.A., Purdue, G.F., Hunt, J.L., and Horton, J.W. (2004) TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 41, 808–813.PubMedGoogle Scholar
  14. Baumann, C.R., Khatami, R., Werth, E., and Bassetti, C.L. (2006) Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J Neurol Neurosurg Psychiatry 77, 402–404.PubMedGoogle Scholar
  15. Ben Baruch, A. (2006) Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 16, 38–52.Google Scholar
  16. Berglund, G., Bolund, C., Fornander, T., Rutqvist, L.E., and Sjoden, P.O. (1991) Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 27, 1075–1081.PubMedGoogle Scholar
  17. Bessler, H., Osovsky, M., and Sirota, L. (2004) Association between IL-1ra gene polymorphism and premature delivery. Biol Neonate 85, 179–183.PubMedGoogle Scholar
  18. Bjorntorp, P., and Rosmond, R. (2000) The metabolic syndrome—A neuroendocrine disorder? Br J Nutr 83(Suppl 1), S49–S57.PubMedGoogle Scholar
  19. Blackburn, C.C., Griffith, J., and Morahan, G. (1995) A high resolution map of the chromosomal region surrounding the nude gene. Genomics 26, 308–317.PubMedGoogle Scholar
  20. Boethel, C.D. (2002) Sleep and the endocrine system: New associations to old diseases. Curr Opin Pulmon Med 8, 502–505.Google Scholar
  21. Bonkovsky, H.L., and Mehta, S. (2001) Hepatitis C: A review and update. J Am Acad Dermatol 44, 159–182.PubMedGoogle Scholar
  22. Bourguignon, C., Labyak, S.E., and Taibi, D. (2003) Investigating sleep disturbances in adults with rheumatoid arthritis. Holist Nurs Pract 17, 241–249.PubMedGoogle Scholar
  23. Bredow, S., Guba-Thakurta, N., Taishi, P., Obal, F., and Krueger, J.M. (1997) Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. Neuroimmunomodulation 4, 84–90.PubMedGoogle Scholar
  24. Buchwald, D., Pascualy, R., Bombardier, C., and Kith, P. (1994) Sleep disorders in patients with chronic fatigue. Clin Infect Dis 18(Suppl 1), S68–S72.PubMedGoogle Scholar
  25. Buchwald, D., Pearlman, T., Umali, J., Schmaling, K., and Katon, W. (1996) Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 171, 364–370.Google Scholar
  26. Bussfeld, D., Kaufmann, A., Meyer, R.G., Gemsa, D., and Sprenger, H. (1998) Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immunol 186, 1–7.PubMedGoogle Scholar
  27. Cannon, J.G. (2000) Inflammatory cytokines in nonpathological states. News Physiol Sci 15, 298–303.PubMedGoogle Scholar
  28. Cantagrel, A., Navaux, F., Loubet-Lescoulie, P., Nourhashemi, F., Enault, G., Abbal, M., Constantin, A., Laroche, M., and Mazieres, B. (1999) Interleukin-1 beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms—Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42, 1093–1100.PubMedGoogle Scholar
  29. Charlton, M.R., Pockros, P.J., and Harrison, S.A. (2006) Impact of obesity on treatment of chronic hepatitis C. Hepatology 43, 1177–1186.PubMedGoogle Scholar
  30. Child, N.J., Yang, I.A., Pulletz, M.C., Courcy-Golder, K., Andrews, A.L., Pappachan, V.J., and Holloway, J.W. (2003) Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem Soc Trans 31, 652–653.PubMedGoogle Scholar
  31. Cleare, A.J. (2003) The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 24, 236–252.PubMedGoogle Scholar
  32. Cleeland, C.S., Bennett, G.J., Dantzer, R., Dougherty, P.M., Dunn, A.J., Meyers, C.A., Miller, A.H., Payne, R., Reuben, J.M., Wang, X.S., and Lee, B.N. (2003) Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokineimmunologic model of cancer symptoms. Cancer 97, 2919–2925.PubMedGoogle Scholar
  33. Cook, D.N., Beck, M.A., Coffman, T.M., Kirby, S.L., Sheridan, J.F., Pragnell, I.B., and Smithies, O. (1995) Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269, 1583–1585.PubMedGoogle Scholar
  34. Cunningham, W.E., Shapiro, M.F., Hays, R.D., Dixon, W.J., Visscher, B.R., George, W.L., Ettl, M.K., and Beck, C.K. (1998) Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 104, 129–134.PubMedGoogle Scholar
  35. Dandona, P., Aljada, A., and Bandyopadhyay, A. (2004) Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 25, 4–7.PubMedGoogle Scholar
  36. Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., and Garg, R. (2005) Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448–1454.PubMedGoogle Scholar
  37. Darko, D.F., McCutchan, J.A., Kripke, D.F., Gillin, J.C., and Golshan, S. (1992) Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry 149, 514–520.PubMedGoogle Scholar
  38. Darko, D.F., Mitler, M.M., and Henriksen, S.J. (1995) Lentiviral infection, immune response peptides and sleep. Adv Neuroimmunol 5, 57–77.PubMedGoogle Scholar
  39. Darko, D.F., Mitler, M.M., and Miller, J.C. (1998) Growth hormone, fatigue, poor sleep, and disability in HIV infection. Neuroendocrinology 67, 317–324.PubMedGoogle Scholar
  40. Dauvilliers, Y., Maret, S., and Tafti, M. (2005) Genetics of normal and pathological sleep in humans. Sleep Med Rev 9, 91–100.PubMedGoogle Scholar
  41. Dauvilliers, Y., Mayer, G., Lecendreux, M., Neidhart, E., Peraita-Adrados, R., Sonka, K., Billiard, M., and Tafti, M. (2002) Kleine-Levin syndrome: An autoimmune hypothesis based on clinical and genetic analyses. Neurology 59, 1739–1745.PubMedGoogle Scholar
  42. Davis, G.L., Balart, L.A., Schiff, E.R., Lindsay, K., Bodenheimer, H.C., Perrillo, R.P., Carey, W., Jacobsen, I.M., Payne, J., Dienstag, J.L., VanThiel, D.H., Tamburro, C., Martino, F.P., Sangvhi, B., and Albrecht, J.K. (1994) Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile. Clin Ther 16, 334–343.PubMedGoogle Scholar
  43. Davis, S. (2004) Clinical sequelae affecting quality of life in the HIV-infected patient. J Assoc Nurses AIDS Care 15, 28S–33S.PubMedGoogle Scholar
  44. De Maeyer, E., and De Maeyer-Guignard, J. (1970) A gene with quantitative effect on circulating interferon induction—Further studies. Ann N Y Acad Sci 173, 228–238.Google Scholar
  45. De Maio, A., Mooney, M.D., Matesic, L.E., Paidas, C.N., and Reeves, R.H. (1998) Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 10, 319–323.PubMedGoogle Scholar
  46. De Sarro, G., Gareri, P., Sinopoli, A., David, E., and Rotiroti, D. (1997) Comparative, behavioural and electrocortical effects of tumor necrosis factor-a and interleukin-1 microinjected into the locus coeruleus of rat. Life Sci 60, 555–564.PubMedGoogle Scholar
  47. Dinarello, C.A. (2006) Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 83, 447S–455S.PubMedGoogle Scholar
  48. Ding, M., and Toth, L.A. (2006) mRNA expression in mouse hypothalamus and basal forebrain during influenza infection: a novel model for sleep regulation. Physiol Genom 24 (3): 225–234.Google Scholar
  49. Ebell, M.H. (2004) Epstein-Barr virus infectious mononucleosis. Am Fam Physician 70, 1279–1287.PubMedGoogle Scholar
  50. El Omar, E.M., Chow, W.H.M., Mccoll, K.E., Fraumeni, J.F., and Rabkin, C.S. (2000) Interleukin-1 beta-enhancing genotypes are associated with increased risk of gastric cancer and its precursors. Gastroenterology 118, A181.Google Scholar
  51. Elenkov, I.J., Iezzoni, D.G., Daly, A., Harris, A.G., and Chrousos, G.P. (2005) Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12, 255–269.PubMedGoogle Scholar
  52. Elmasry, A., Janson, C., Lindberg, E., Gislason, T., Tageldin, M.A., and Boman, G. (2000) The role of habitual snoring and obesity in the development of diabetes: A 10-year followup study in a male population. J Intern Med 248, 11–20.Google Scholar
  53. Elmasry, A., Lindberg, E., Berne, C., Janson, C., Gislason, T., Awad Tageldin, M., and Boman, G. (2001) Sleep-disordered breathing and glucose metabolism in hypertensive men: A population-based study. J Intern Med 249, 153–161.PubMedGoogle Scholar
  54. Ershler, W.B., and Keller, E.T. (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51, 245–270.PubMedGoogle Scholar
  55. Fang, J., Wang, Y., and Krueger, J.M. (1997) Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J Neurosci 17, 5949–5955.PubMedGoogle Scholar
  56. Fantuzzi, G. (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911–919.PubMedGoogle Scholar
  57. Fernandez-Real, J.M. (2006) Genetic predispositions to low-grade inflammation and type 2 diabetes. Diabetes Technol Ther 8, 55–66.PubMedGoogle Scholar
  58. Fincher, E.F., Johannsen, L., Kapás, L., Takahashi, S., and Krueger, J.M. (1996) Microglia digest Staphylococcus aureus into low molecular weight biologically active compounds. Am J Physiol 271, R149–R156.PubMedGoogle Scholar
  59. Finegood, D.T. (2003) Obesity, inflammation and type II diabetes. Int J Obes Relat Metab Disord 27 Suppl 3, S4–S5.PubMedGoogle Scholar
  60. Floyd, R.A., and Krueger, J.M. (1997) Diurnal variation of TNF alpha in the rat brain. NeuroReport 3, 915–918.Google Scholar
  61. Forton, D.M., Taylor-Robinson, S.D., and Thomas, H.C. (2006) Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 18, 333–338.PubMedGoogle Scholar
  62. Franken, P., Chollet, D., and Tafti, M. (2001a) The homeostatic regulation of sleep need is under genetic control. J Neurosci 21, 2610–2621.Google Scholar
  63. Franken, P., Chollet, D., and Tafti, M. (2001b) The homeostatic regulation of sleep need is under genetic control. J Neurosci 21, 2610–2621.Google Scholar
  64. Franken, P., Malafosse, A., and Tafti, M. (1998) Genetic variation in EEG activity during sleep in inbred mice. Am J Physiol 275, R1127–R1137.PubMedGoogle Scholar
  65. Fukuda, K., Straus, S.E., Hickie, I., Sharpe, M.C., Dobbins, J.G., and Komaroff, A.L. (1994) The chronic fatigue syndrome: A comprehensive approach to its definition and study (International Chronic Fatigue Study Group). Ann Intern Med 121, 953–999.PubMedGoogle Scholar
  66. Gabay, C., and Kushner, I. (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340, 448–454.PubMedGoogle Scholar
  67. Gedda, L. (1951) Studio dei Gemelli. Orizzonte Medico, Roma.Google Scholar
  68. Gedda L., and Brenci G. (1983) Twins living apart test: Progress report. Acta Genet Med Gemellol (Roma) 32, 17–22.Google Scholar
  69. Gerhardt, C.C., Romero, I.A., Cancello, R., Camoin, L., and Strosberg, A.D. (2001) Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 175, 81–92.PubMedGoogle Scholar
  70. Gerli, R., Monti, D., Bistoni, O., Mazzone, A.M., Peri, G., Cossarizza, A., Di Gioacchino, M., Cesarotti, M.E., Doni, A., Mantovani, A., Franceschi, C., and Paganelli, R. (2000) Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev 121, 37–46.PubMedGoogle Scholar
  71. Geyer, H. (1937) Ueber den Schlaf von Zwillingen. Z Indukt Abstamm Verebungsl 78, 524–527.Google Scholar
  72. Giuliani, N., Sansoni, P., Girasole, G., Vescovini, R., Passeri, G., Passeri, M., and Pedrazzoni, M. (2001) Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 36, 547–557.PubMedGoogle Scholar
  73. Glaser, R., and Kiecolt-Glaser, J.K. (1998) Stress-associated immune modulation: Relevance to viral infections and chronic fatiigue syndrome. Am J Med 105, 35S–42S.PubMedGoogle Scholar
  74. Glaser, R., Padgett, D.A., Litsky, M.L., Baiocchi, R.A., Yang, E.V., Chen, M., Yeh, P.E., Klimas, N.G., Marshall, G.D., Whiteside, T., Herberman, R., Kiecolt-Glaser, J., and Williams, M.V. (2005) Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: Implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19, 91–103.PubMedGoogle Scholar
  75. Godfrey, P., Rahal, J.O., Beamer, W.G., Copeland, N.G., Jenkins, N.A., and Mayo, K.E. (1993) GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4, 227–232.PubMedGoogle Scholar
  76. Gong, J.H., Sprenger, H., Hinder, F., Bender, A., Schmidt, A., Horch, S., Nain, M., and Gemsa, D. (1991) Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol 147, 3507–3513.PubMedGoogle Scholar
  77. Gottlieb, D.J., DeStefano, A.L., Foley, D.J., Mignot, E., Redline, S., Givelber, R.J., and Young, T. (2004) APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: The Sleep Heart Health Study. Neurology 63, 664–668.PubMedGoogle Scholar
  78. Guan, Z., Vgontzas, A.N., Omori, T., Peng, X., Bixler, E.O., and Fang, J. (2005) Interleukin-6 levels fluctuate with the light-dark cycle in the brain and peripheral tissues in rats. Brain Behav Immun 19, 526–529.PubMedGoogle Scholar
  79. Gudewill, S., Pollmächer, T., Vedder, H., Schreiber, W., Fassbender, K., and Holsboer, F. (1992) Nocturnal plasma levels of cytokines in healthy men. Eur Arch Psychiatr Clin Neurosci 242, 53–56.Google Scholar
  80. Guilleminault, C., and Mondini, S. (1986) Mononucleosis and chronic daytime sleepiness: A longterm follow-up study. Arch Intern Med 146, 1333–1335.PubMedGoogle Scholar
  81. Haffner, S.M., Ruilope, L., Dahlof, B., Abadie, E., Kupfer, S., and Zannad, F. (2006) Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials. J Cardiovasc Pharmacol 47, 469–475.PubMedGoogle Scholar
  82. Hamajima, N., Matsuo, K., Saito, T., Tajima, K., Okuma, K., Yamao, K., and Tominaga, S. (2001) Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 92, 383–389.PubMedGoogle Scholar
  83. Hartel, C., von Puttkamer, J., Gallner, F., Strunk, T., and Schultz, C. (2004) Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: Potential role of cyclooxygenase-2 inhibition. Scand J Immunol 60, 412–420.PubMedGoogle Scholar
  84. Heath, A.C., Kendler, K.S., Eaves, L.J., and Martin, N.G. (1990) Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep 13, 318–335.PubMedGoogle Scholar
  85. Hector, R.F., Domer, J.E., and Carrow, E.W. (1982) Immune response to Candida albicans in genetically distinct mice. Infect Immun 38, 1020–1028.PubMedGoogle Scholar
  86. Heesen, M., Kunz, D., Bachmann-Mennenga, B., Merk, H.F., and Bloemeke, B. (2003) Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 31, 211–214.PubMedGoogle Scholar
  87. Hofmann, P., Sprenger, H., Kaufmann, A., Bender, A., Hasse, C., Nain, M., and Gemsa, D. (1997) Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol 61, 408–414.PubMedGoogle Scholar
  88. Ip, M.S.M., Lam, B., Ng, M.M.T., Lam, W.K., Tsang, K.W.T., and Lam, K.S.L. (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 166, 670–676.Google Scholar
  89. Jenkins, J.B., Omori, T., Guan, Z., Vgontzas, A.N., Bixler, E.O., and Fang, J. (2005) Sleep is increased in mice with obesity induced by high-fat food. Physiol Behav 87, 255–262.PubMedGoogle Scholar
  90. Johannsen, L., Wecke, J., Obál, F., and Krueger, J.M. (1991) Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci. Am J Physiol 260, R126–R133.PubMedGoogle Scholar
  91. Jones, C.R., and Ptacek, L.J. (1999) Familial advanced sleep phase syndrome: An autosomal dominant circadian rhythm variant in humans. Neurology 52, A109–A110.Google Scholar
  92. Jones, J.F., Williams, M., and Schooley, R.T. (1988) Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Arch Intern Med 148, 1957–1960.PubMedGoogle Scholar
  93. Josephs, S.F., Henry, B., Balachandran, N., Strayer, D., Peterson, D., Komaroff, A.L., and Ablashi, D.V. (1991) HHV-6 reactivation in chronic fatigue syndrome. Lancet 337, 1346–1347.PubMedGoogle Scholar
  94. Juji, T., Satake, M., Honda, Y., and Doi, Y. (1984) HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24, 316–319.PubMedGoogle Scholar
  95. Kapsimalis, F., Richardson, G., Opp, M.R., and Kryger, M. (2005) Cytokines and normal sleep. Curr Opin Pulm Med 11, 481–484.PubMedGoogle Scholar
  96. Kimura-Takeuchi, M., Majde, J.A., Toth, L.A., and Krueger, J.M. (1992a) Influenza virusinduced changes in rabbit sleep and acute phase responses. Am J Physiol 263, R1115–R1121.Google Scholar
  97. Kimura-Takeuchi, M., Majde, J.A., Toth, L.A., and Krueger, J.M. (1992b) The role of doublestranded RNA in induction of the acute-phase response in an abortive influenza virus infection model. J Infect Dis 166, 1266–1275.Google Scholar
  98. Knobler, H., and Schattner, A. (2005) TNF-alpha, chronic hepatitis C and diabetes: A novel triad. QJM 98, 1–6.PubMedGoogle Scholar
  99. Knobler, H., Schihmanter, R., Zifroni, A., Fenakel, G., and Schattner, A. (2000) Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 75, 355–359.PubMedGoogle Scholar
  100. Kornman, K.S. (2006) Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 83, 475S–483S.PubMedGoogle Scholar
  101. Korth, C., Mullington, J., Schreiber, W., and Pollmacher, T. (1996) Influence of endotoxin on daytime sleep in humans. Infect Immun 64, 1110–1115.PubMedGoogle Scholar
  102. Kritchevsky, S.B., Cesari, M., and Pahor, M. (2005) Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 66, 265–275.PubMedGoogle Scholar
  103. Krueger, J.M., and Toth, L.A. (1994) Cytokines as regulators of sleep. Ann N Y Acad Sci 739, 299–310.PubMedGoogle Scholar
  104. Kuhns, D.B., Priel, D.A.L., and Gallin, J.I. (1997) Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J Immunol 158, 3959–3964.PubMedGoogle Scholar
  105. Kulbe, H., Hagemann, T., Szlosarek, P.W., Balkwill, F.R., and Wilson, J.L. (2005) The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 65, 10355–10362.PubMedGoogle Scholar
  106. Lancel, M., Cronlein, J., Muller-Preuss, P., and Holsboer, F. (1995) Lipopolysaccharide increases EEG delta activity within non-REM sleep and disrupts sleep continuity in rats. Am J Physiol 268, R1310–R1318.PubMedGoogle Scholar
  107. Lang, C.A., Conrad, S., Garrett, L., Battistutta, D., Cooksley, W.G., Dunne, M.P., and Macdonald, G.A. (2006) Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. J Pain Symptom Manage 31, 335–344.PubMedGoogle Scholar
  108. Laposky, A.D., Shelton, J., Bass, J., Dugovic, C., Perrino, N., and Turek, F.W. (2006) Altered sleep regulation in leptin-deficient mice. Am J Physiol 290, R1–R10.Google Scholar
  109. Larkin, E.K., Patel, S.R., Redline, S., Mignot, E., Elston, R.C., and Hallmayer, J. (2006) Apolipoprotein E and obstructive sleep apnea: Evaluating whether a candidate gene explains a linkage peak. Genet Epidemiol 30, 101–110.PubMedGoogle Scholar
  110. Lashley, F.R. (2003) A review of sleep in selected immune and autoimmune disorders. Holist Nurs Pract 17, 65–80.PubMedGoogle Scholar
  111. Lee, B.N., Dantzer, R., Langley, K.E., Bennett, G.J., Dougherty, P.M., Dunn, A.J., Meyers, C.A., Miller, A.H., Payne, R., Reuben, J.M., Wang, X.S., and Cleeland, C.S. (2004) A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11, 279–292.PubMedGoogle Scholar
  112. Leproult, R., Copinschi, G., Buxton, O., and Van Cauter, E. (1997) Sleep loss results in an elevation of cortisol levels in the next evening. Sleep 20, 865–870.PubMedGoogle Scholar
  113. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X.Y., Qiu, X.H., de Jong, P.J., Nishino, S., and Mignot, E. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365–376.PubMedGoogle Scholar
  114. Lin, L., Hungs, M., and Mignot, E. (2001) Narcolepsy and the HLA region. J Neuroimmunol 117, 9–20.PubMedGoogle Scholar
  115. Lin, S.-C., Lin, C.R., Gukovsky, I., Lusis, A.J., Sawchenko, P.E., and Rosenfeld, M.G. (1993) Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364, 208–213.PubMedGoogle Scholar
  116. Linkowski, P. (1999) EEG sleep patterns in twins. J Sleep Res 8(Suppl 1), 11–13.PubMedGoogle Scholar
  117. Loffreda, S., Yang, S.Q., Lin, H.Z., Karp, C.L., Brengman, M.L., Wang, D.J., Klein, A.S., Bulkley, G.B., Bao, C., Noble, P.W., Lane, M.D., and Diehl, A.M. (1998) Leptin regulates proinflammatory immune responses. FASEB J 12, 57–65.PubMedGoogle Scholar
  118. Lorenz, E., Mira, J.P., Frees, K.L., and Schwartz, D.A. (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162, 1028–1032.PubMedGoogle Scholar
  119. Lu, B., Rutledge, B.J., Gu, L., Fiorillo, J., Lukacs, N.W., Kunkel, S.L., North, R., Gerard, C., and Rollins, B.J. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187, 601–608.PubMedGoogle Scholar
  120. Lugaresi, E., Medori, R., Montagna, P., Baruzzi, A., Cortelli, P., Lugaresi, A., Tinuper, P., Zucconi, M., and Gambetti, P. (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315, 997–1003.PubMedGoogle Scholar
  121. Maggio, M., Guralnik, J.M., Longo, D.L., and Ferrucci, L. (2006) Interleukin-6 in aging and chronic disease: A magnificent pathway. J Gerontol A Biol Sci Med Sci 61, 575–584.PubMedGoogle Scholar
  122. Maret, S., Franken, P., Dauvilliers, Y., Ghyselinck, N.B., Chambon, P., and Tafti, M. (2005) Retinoic acid signaling affects cortical synchrony during sleep. Science 310, 111–113.PubMedGoogle Scholar
  123. Marquis, G., Montplaisir, S., Pelletier, M., Auger, P. and Lapp, W.S. (1988) Genetics of resistance to infection with candida-albicans in mice. Br J Exp Pathol 69, 651–660.PubMedGoogle Scholar
  124. Marquis, G., Montplaisir, S., Pelletier, M., Mousseau, S., and Auger, P. (1986) Straindependent differences in susceptibility of mice to experimental candidosis. J Infect Dis 154, 906–909.PubMedGoogle Scholar
  125. Marshall, L., and Born, J. (2002) Brain-immune interactions in sleep. Int Rev Neurobiol 52, 93–131.PubMedGoogle Scholar
  126. Martin, W.J. (1996) Severe stealth virus encephalopathy following chronic-fatigue-syndromelike illness: Clinical and histopathological features. Pathobiol 64, 1–8.Google Scholar
  127. Mathias, S., Schiffelholz, T., Linthorst, A.C., Pollmacher, T., and Lancel, M. (2000) Diurnal variations in lipopolysaccharide-induced sleep, sickness behavior and changes in corticosterone levels in the rat. Neuroendocrinology 71, 375–385.PubMedGoogle Scholar
  128. Mattson, K., Niiranen, A., Iivanainen, M., Farkkila, M., Bergstrom, L., Holsti, L.R., Kauppinen, H.L., and Cantell, K. (1983) Neurotoxicity of interferon. Cancer Treat Rep 67, 958–961.PubMedGoogle Scholar
  129. Mcgeer, P.L., and Mcgeer, E.G. (2001) Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 58, 1790–1792.PubMedGoogle Scholar
  130. Medori, R., Tritschler, H.J., Leblanc, A., Villare, F., Manetto, V., Chen, H.Y., Xue, R., Leal, S., Montagna, P., Cortelli, P., Tinuper, P., Avoni, P., Mochi, M., Baruzzi, A., Hauw, J.J., Ott, J., Lugaresi, E., Autiliogambetti, L., and Gambetti, P. (1992) Fatal familial insomnia, a prion disease with a mutation at Codon-178 of the prion protein gene. N Engl J Med 326, 444–449.PubMedGoogle Scholar
  131. Mehta, S.H., Brancati, F.L., Sulkowski, M.S., Strathdee, S.A., Szklo, M., and Thomas, D.L. (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133, 592–599.PubMedGoogle Scholar
  132. Mignot, E., Wang, C., Rattazzi, C., Gaiser, C., Lovett, M., Guilleminault, C., Dement, W.C., and Grumet, F.C. (1991) Genetic-linkage of autosomal recessive canine narcolepsy with A Mu-immunoglobulin heavy-chain switch-like segment. Proc Natl Acad Sci U S A 88, 3475–3478.PubMedGoogle Scholar
  133. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., Klein, S., and Coppack, S.W. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82, 4196–4200.PubMedGoogle Scholar
  134. Morriss, R., Sharpe, M., Sharpley, A.L., Cowen, P.J., Hawton, K., and Morris, J. (1993) Abnormalities of sleep in patients with the chronic fatigue syndrome. Br Med J 306, 1161–1164.Google Scholar
  135. Morrow, G.R., Andrews, P.L., Hickok, J.T., Roscoe, J.A., and Matteson, S. (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10, 389–398.PubMedGoogle Scholar
  136. Mullington, J., Korth, C., Hermann, D.M., Orth, A., Galanos, C., Holsboer, F., and Pollmacher, T. (2000) Dose-dependent effects of endotoxin on human sleep. Am J Physiol Regul Integr Comp Physiol 278, R947–R955.PubMedGoogle Scholar
  137. Natelson, B.H., Ye, D., Moul, D.E., Jenkins, F.J., Oren, D.A., Tapp, W.N., and Cheng, Y.-C. (1994) High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol 42, 42–46.PubMedGoogle Scholar
  138. Nishino, S., Ripley, B., Overeem, S., Lammers, G.J., and Mignot, E. (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39–40.PubMedGoogle Scholar
  139. Norman, S.E., Chediak, H.D., Kiel, M., and Cohn, M.A. (1990) Sleep disturbances in HIVinfected homosexual men. AIDS 4, 775–781.PubMedGoogle Scholar
  140. O'Donnell, C.P., Schaub, C.D., Haines, A.S., Berkowitz, D.E., Tankersley, C.G., Schwartz, A.R., and Smith, P.L. (1999) Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 159, 1477–1484.PubMedGoogle Scholar
  141. Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., and Flegal, K.M. (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295, 1549–1555.PubMedGoogle Scholar
  142. Opp, M.R., Kapás, L., and Toth, L.A. (1992) Cytokine involvement in the regulation of sleep. Proc Soc Exp Biol Med 201, 16–27.PubMedGoogle Scholar
  143. Papanicolaou, D.A., Amsterdam, J.D., Levine, S., McCann, S.M., Moore, R.C., Newbrand C.H., Allen, G., Nisenbaum, R., Pfaff, D.W., Tsokos, G.C., Vgontzas, A.N., and Kales, A. (2004) Neuroendocrin aspects of chronic fatigue syndrome. Neuroimmunomodulation 11, 66–74.Google Scholar
  144. Partinen, M., Kaprio, J., Koskenvuo, M., Putkonen, P., and Langinvainio, H. (1983) Genetic and environmental determination of human sleep. Sleep 6, 179–185.PubMedGoogle Scholar
  145. Petersen, I., Thomas, J.M., Hamilton, W.T., and White, P.D. (2006) Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. QJM 99, 49–55.PubMedGoogle Scholar
  146. Petrides, A.S., and DeFronzo, R.A. (1989) Glucose and insulin metabolism in cirrhosis. J Hepatol 8, 107–114.PubMedGoogle Scholar
  147. Petrides, A.S., Schulze-Berge, D., Vogt, C., Matthews, D.E., and Strohmeyer, G. (1993) Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 18, 284–291.PubMedGoogle Scholar
  148. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., Li, R., Hungs, M., Pedrazzoli, M., Padigaru, M., Kucherlapati, M., Fan, J., Maki, R., Lammers, G.J., Bouras, C., Kucherlapati, R., Nishino, S., and Mignot, E. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6, 991–997.PubMedGoogle Scholar
  149. Plazzi, G., Montagna, P., Beelke, M., Nobili, L., De Carli, F., Cortelli, P., Vandi, S., Avoni, P., Tinuper, P., Gambetti, P., Lugaresi, E., and Ferrillo, F. (2002) Does the prion protein gene 129 codon polymorphism influence sleep? Evidence from a fatal familial insomnia kindred. Clin Neurophysiol 113, 1948–1953.PubMedGoogle Scholar
  150. Pollmacher, T., Schuld, A., Kraus, T., Haack, M., Hinze-Selch, D., and Mullington, J. (2000) Experimental immunomodulation, sleep, and sleepiness in humans. Ann N Y Acad Sci 917, 488–499.PubMedGoogle Scholar
  151. Poltorak, A., He, X.L., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085–2088.PubMedGoogle Scholar
  152. Prinz, P.N. (2004) Age impairments in sleep, metabolic and immune functions. Exp Gerontol 39, 1739–1743.PubMedGoogle Scholar
  153. Punjabi, N.M., Sorkin, J.D., Katzel, L.I., Goldberg, A.P., Schwartz, A.R., and Smith, P.L. (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165, 677–682.PubMedGoogle Scholar
  154. Pusztai, L., Mendoza, T.R., Reuben, J.M., Martinez, M.M., Willey, J.S., Lara, J., Syed, A., Fritsche, H.A., Bruera, E., Booser, D., Valero, V., Arun, B., Ibrahim, N., Rivera, E., Royce, M., Cleeland, C.S., and Hortobagyi, G.N. (2004) Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 25, 94–102.PubMedGoogle Scholar
  155. Qin, L.Q., Li, J., Wang, Y., Wang, J., Xu, J.Y., and Kaneko, T. (2003) The effects of nocturnal life on endocrine circadian patterns in healthy adults. Life Sci 73, 247–2475.Google Scholar
  156. Qureshi, S.T., Lariviere, L., Sebastiani, G., Clermont, S., Skamene, E., Gros, P., and Malo, D. (1996) A high-resolution map in the chromosomal region surrounding the Lps locus. Genomics 31, 283–294.PubMedGoogle Scholar
  157. Reid, S., and Dwyer, J. (2005) Insomnia in HIV infection: A systematic review of prevalence, correlates, and management. Psychosom Med 67, 260–269.PubMedGoogle Scholar
  158. Resnick, H.E., Redline, S., Shahar, E., Gilpin, A., Newman, A., Walter, R., Ewy G.A., Howard, B.V., and Punjabi, N.M. (2003) Diabetes and sleep disturbances. Diabetes Care 26, 702–709.PubMedGoogle Scholar
  159. Riha, R.L., Brander, P., Vennelle, M., McArdle, N., Kerr, S.M., Anderson, N.H., and Douglas, N.J. (2005) Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 26, 673–678.PubMedGoogle Scholar
  160. Saarelainen, S., Lehtimaki, T., Nikkila, M., Solakivi, T., Nieminen, M.M., and Jaakkola, O. (2000) Association between apolipoprotein E alleles and autoantibodies against oxidised low-density lipoprotein. Clin Chem Lab Med 38, 477–478.PubMedGoogle Scholar
  161. Sairenji, T., Yamanishi, K., Tachibana, Y., Bertoni, G., and Kurata, T. (1995) Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirol 38, 269–273.Google Scholar
  162. Sakai, K., Takada, T., Nakayama, H., Kubota, Y., Nakamata, M., Satoh, M., Suzuki, E., Akazawa, K., and Gejyo, F. (2005) Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea. Intern Med 44, 928–933.PubMedGoogle Scholar
  163. Saleh, M., Vaillancourt, J.P., Graham, R.K., Huyck, M., Srinivasula, S.M., Alnemri, E.S., Steinberg, M.H., Nolan, V., Baldwin, C.T., Hotchkiss, R.S., Buchman, T.G., Zehnbauer, B.A., Hayden, M.R., Farrer, L.A., Roy, S., and Nicholson, D.W. (2004) Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429, 75–79.PubMedGoogle Scholar
  164. Sartipy, P., and Loskutoff, D.J. (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100, 7265–7270.PubMedGoogle Scholar
  165. Savard, J., Simard, S., Hervouet, S., Ivers, H., Lacombe, L., and Fradet, Y. (2005) Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncology 14, 147–156.PubMedGoogle Scholar
  166. Schenck, C.H., Garcia-Rill, E., Segall, M., Noreen, H., and Mahowald, M.W. (1996) HLA class II genes associated with REM sleep behavior disorder. Ann Neurol 39, 261–263.PubMedGoogle Scholar
  167. Schiffelholz, T., and Lancel, M. (2001) Sleep changes induced by lipopolysaccharide in the rat are influenced by age. Am J Physiol Regul Integr Comp Physiol 280, R398–R403.PubMedGoogle Scholar
  168. Shearer, W.T., Reuben, J.M., Mullington, J.M., Price, N.J., Lee, B.N., Smith, E.O., Szuba, M.P., Van Dongen, H.P.A., and Dinges, D.F. (2001) Soluble TNF-a receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of space flight. J Allergy Clin Immunol 107, 165–170.PubMedGoogle Scholar
  169. Smedley, H., Katrak, M., Sikora, K., and Wheeler, T. (1983) Neurological effects of human recombinant interferon. Br Med J 286, 262–265.Google Scholar
  170. Smith, A. (1992) Sleep, colds, and performance. In: R.J. Broughton and R.D. Ogilvie (Eds.), Sleep, Arousal and Performance. Birkhauser, Boston, pp. 233–242.Google Scholar
  171. Spath-Schwalbe, E., Hansen, K., Schmidt, F., Schrezenmeier, H., Marshall, L., Burger, K., Fehm, H.L., and Born, J. (1998) Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 83, 1573–1579.PubMedGoogle Scholar
  172. Spath-Schwalbe, E., Lange, T., Perras, B., Horst, B., Fehm, H.L., and Born, J. (2000) Interferon-a acutely impairs sleep in healthy humans. Cytokine 12, 518–521.PubMedGoogle Scholar
  173. Spiegel, K., Knutson, K., Leproult, R., Tasali, E., and Van Cauter, E. (2005a) Sleep loss: A novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99, 2008–2019.Google Scholar
  174. Spiegel, K., Leproult, R., and Van Cauter, E. (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354, 1435–1439.PubMedGoogle Scholar
  175. Spiegel, K., Tasali, E., Penev, P., and Van Cauter, E. (2004) Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141, 846–850.PubMedGoogle Scholar
  176. Spiegel, B.M., Younossi, Z.M., Hays, R.D., Revicki, D., Robbins, S., and Kanwal, F. (2005b) Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology 41, 790–800.Google Scholar
  177. Strunk, T., and Burgner, D. (2006) Genetic susceptibility to neonatal infection. Curr Opin Infect Dis 19, 259–263.PubMedGoogle Scholar
  178. Swanink, C.M.A., van der Meer, J.W.M., Vercoulen, J.H.M.M., Bleijenberg, G., Fennis, J.F.M., and Galama, J.M.D. (1995) Epstein-Barr virus (EBV) and the chronic fatigue syndrome: Normal virus load in blood and normal immunologic reacitivity in the EBV regression assay. Clin Infect Dis 20, 1390–1392.PubMedGoogle Scholar
  179. Tafti, M., Franken, P., Kitahama, K., Malafosse, A., Jouvet, M., and Valatx, J.L. (1997) Localization of candidate genomic regions influencing paradoxical sleep in mice. Neuroreport 8, 3755–3758.PubMedGoogle Scholar
  180. Tafti, M., Petit, B., Chollet, D., Neidhart, E., de Bilbao, F., Kiss, J.Z., Wood, P.A., and Franken, P. (2003) Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nat Genet 34, 320–325.PubMedGoogle Scholar
  181. Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S., Ishihara, A., Kanatani, A., Itadani, H., and Kotani, H. (2003) Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278, 46654–46660.PubMedGoogle Scholar
  182. Temelkova-Kurktschiev, T., Henkel, E., Koehler, C., Karrei, K., and Hanefeld, M. (2002) Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance. Diabetologia 45, 151.PubMedGoogle Scholar
  183. Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., and Siegel, J.M. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469–474.PubMedGoogle Scholar
  184. Tobi, M., and Strauss, S.E. (1988) Chronic mononucleosis—A legitimate diagnosis. Postgrad Med 83, 69–78.PubMedGoogle Scholar
  185. Toh, K.L., Jones, C.R., He, Y., Eide, E.J., Hinz, W.A., Virshup, D.M., Ptacek, L.J., and Fu, Y.H. (2001) An hPer2 phosphorylation site mutation in familiar advanced sleep phase syndrome. Science 291, 1040–1043.PubMedGoogle Scholar
  186. Toth, L.A. (1996) Strain differences in the somnogenic effects of interferon inducers in mice. J Interferon Cytokine Res 16, 1065–1072.PubMedGoogle Scholar
  187. Toth, L.A., and Hughes, L.F. (2004) Macrophage participation in influenza-induced sleep enhancement in C57BL/6J mice. Brain Behav Immun 18, 375–389.PubMedGoogle Scholar
  188. Toth, L.A., Hughes, L.F. (2006) Sleep and temperature responses of inbred mice with Candida albicans-induced pyelonephritis. Comp Med 56(4): 252–261.PubMedGoogle Scholar
  189. Toth, L.A., and Krueger, J.M. (1988) Alteration of sleep in rabbits by Staphylococcus aureus infection. Infect Immun 56, 1785–1791.PubMedGoogle Scholar
  190. Toth, L.A., and Krueger, J.M. (1989) Effects of microbial challenge on sleep in rabbits. FASEB J 3, 2062–2066.PubMedGoogle Scholar
  191. Toth, L.A., and Krueger, J.M. (1990a) Infectious disease, cytokines and sleep. In: M. Mancia and G. Marini (Eds.), The Diencephalon and Sleep. Raven Press, New York, pp. 331–341.Google Scholar
  192. Toth, L.A., and Krueger, J.M. (1990b) Somnogenic, pyrogenic and hematologic effects of experimental pasteurellosis in rabbits. Am J Physiol 258, R536–R542.Google Scholar
  193. Toth, L.A., Rehg, J.E., and Webster, R.G. (1995) Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J Neuroimmunol 58, 89–99.PubMedGoogle Scholar
  194. Toth, L.A., and Verhulst, S.J. (2003) Strain differences in sleep patterns of healthy and influenza-infected inbred mice. Behav Genet 33, 325–336.PubMedGoogle Scholar
  195. Toth, L.A., and Williams, R.W. (1999a) A quantitative genetic analysis of locomotor activity in CXB recombinant inbred mice. Behav Genet 29, 319–328.Google Scholar
  196. Toth, L.A., and Williams, R.W. (1999b) A quantitative genetic analysis of slow-wave sleep and rapid-eye movement sleep in CXB recombinant inbred mice. Behav Genet 29, 329–337.Google Scholar
  197. Toth, L.A., and Williams, R.W. (1999c) A quantitative genetic analysis of slow-wave sleep in influenza-infected CXB recombinant inbred mice. Behav Genet 29, 339–348.Google Scholar
  198. Tuite, A., Elias, M., Picard, S., Mullick, A., and Gros, P. (2005) Genetic control of suceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun 6, 672–682.PubMedGoogle Scholar
  199. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., and Hotamisligil, G.S. (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610–614.PubMedGoogle Scholar
  200. Vallance, B.A., Deng, W., Jacobson, K., and Finlay, B.B. (2003) Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 71, 3443–3453.PubMedGoogle Scholar
  201. Van Cauter, E., Blackman, J.D., Roland, D., Spire, J.P., Refetoff, S., and Polonsky, K.S. (1991) Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 88, 834–942.Google Scholar
  202. Vance, D.E., and Burrage, J.W., Jr. (2005) Sleep disturbances and psychomotor decline in HIV. Percept Mot Skills 100, 1004–1010.PubMedGoogle Scholar
  203. Vettor, R., Milan, G., Rossato, M., and Federspil, G. (2005) Review article: Adipocytokines and insulin resistance. Aliment Pharmacol Ther 22(Suppl 2), 3–10.PubMedGoogle Scholar
  204. Vgontzas, A.N., Bixler, E.O., Lin, H.M., Prolo, P., Trakada, G., and Chrousos, G.P. (2005) IL- 6 and its circadian secretion in humans. Neuroimmunomodulation 12, 131–140.PubMedGoogle Scholar
  205. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Kales, A., Tyson, K., and Chrousos, G.P. (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 82, 1313–1316.PubMedGoogle Scholar
  206. Vogel, F. (1965) [“14 and 6/sec positive spikes” in the sleep EEG of young mono-and dizygotic twins]. Humangenetik 1, 390–391.PubMedGoogle Scholar
  207. Vosvick, M., Gore-Felton, C., Ashton, E., Koopman, C., Fluery, T., Israelski, D., and Spiegel, D. (2004) Sleep disturbances among HIV-positive adults: The role of pain, stress, and social support. J Psychosom Res 57, 459–463.PubMedGoogle Scholar
  208. Webb, W.B., and Campbell, S.S. (1983) Relationships in sleep characteristics of identical and fraternal twins. Arch Gen Psychiatry 40, 1093–1095.PubMedGoogle Scholar
  209. Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R.L., and Ferrante, A.W., Jr. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116, 115–124.PubMedGoogle Scholar
  210. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and Ferrante, A.W., Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.PubMedGoogle Scholar
  211. Wellen, K.E., and Hotamisligil, G.S. (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111–1119.PubMedGoogle Scholar
  212. White, P.D., Thomas, J.M., Amess, J., Crawford, D.H., Grover, S.A., Kangro, H.O., and Clare, A.W. (1998) Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatr 173, 475–481.Google Scholar
  213. White, P.D., Thomas, J.M., Sullivan, P.F., and Buchwald, D. (2004) The nosology of subacute and chronic fatigue syndromes that follow infectious mononucleosis. Psychol Med 34, 499–507.PubMedGoogle Scholar
  214. Wilson, J., and Balkwill, F. (2002) The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12, 113–120.PubMedGoogle Scholar
  215. Wilson, S.D., Billings, P.R., D'Eustachio, P., Fournier, R.E., Geissler, E., Lalley, P.A., Burd, P.R., Housman, D.E., Taylor, B.A., and Dorf, M.E. (1990) Clustering of cytokine genes on mouse chromosome 11. J Exp Med 171, 1301–1314.PubMedGoogle Scholar
  216. Wilson, I., McNamara, S.G., and Collins, F.L. (1998) “Syndrome Z”: The interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53 (Suppl 3), S25–S28.Google Scholar
  217. Wong, W., and Terrault, N. (2005) Update on chronic hepatitis C. Clin. Gastroenterol Hepatol 3, 507–520.PubMedGoogle Scholar
  218. World Health Organization (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6, 35–47.Google Scholar
  219. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821–1830.PubMedGoogle Scholar
  220. Yudkin, J.S., Kumari, M., Humphries, S.E., and Mohamed-Ali, V. (2000) Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148, 209–214.PubMedGoogle Scholar
  221. Zhang, J., Zhao, B., Gesongluobu Sun, Y.H., Wu, Y., Pei, W.D., Ye, J., Hui, R.T., and Liu, L.S. (2000) Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea. Hypertension Res 23, 407–411.Google Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Rita A. Trammell
  • Krishna Jhaveri
  • Linda A. Toth

There are no affiliations available

Personalised recommendations